ALEC
Price
$1.02
Change
-$0.07 (-6.42%)
Updated
Apr 4, 04:30 PM (EDT)
Capitalization
108M
27 days until earnings call
EYEN
Price
$0.99
Change
-$0.12 (-10.81%)
Updated
Apr 4, 03:53 PM (EDT)
Capitalization
2.32M
40 days until earnings call
Ad is loading...

ALEC vs EYEN

Header iconALEC vs EYEN Comparison
Open Charts ALEC vs EYENBanner chart's image
Alector
Price$1.02
Change-$0.07 (-6.42%)
Volume$6.35K
Capitalization108M
Eyenovia
Price$0.99
Change-$0.12 (-10.81%)
Volume$350
Capitalization2.32M
ALEC vs EYEN Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. EYEN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and EYEN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ALEC: $1.09 vs. EYEN: $1.11)
Brand notoriety: ALEC and EYEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 119% vs. EYEN: 8%
Market capitalization -- ALEC: $108M vs. EYEN: $2.32M
ALEC [@Biotechnology] is valued at $108M. EYEN’s [@Biotechnology] market capitalization is $2.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileEYEN’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • EYEN’s FA Score: 1 green, 4 red.
According to our system of comparison, EYEN is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while EYEN’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 4 bearish.
  • EYEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EYEN is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а -18.05% price change this week, while EYEN (@Biotechnology) price change was -11.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.99%. For the same industry, the average monthly price growth was -16.86%, and the average quarterly price growth was -18.44%.

Reported Earning Dates

ALEC is expected to report earnings on May 01, 2025.

EYEN is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (-10.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($108M) has a higher market cap than EYEN($2.32M). ALEC YTD gains are higher at: -42.328 vs. EYEN (-90.497). EYEN has higher annual earnings (EBITDA): -34.09M vs. ALEC (-136.16M). ALEC has more cash in the bank: 413M vs. EYEN (26.7M). EYEN has less debt than ALEC: EYEN (13M) vs ALEC (42.5M). ALEC has higher revenues than EYEN: ALEC (101M) vs EYEN (31.8K).
ALECEYENALEC / EYEN
Capitalization108M2.32M4,647%
EBITDA-136.16M-34.09M399%
Gain YTD-42.328-90.49747%
P/E RatioN/AN/A-
Revenue101M31.8K317,610%
Total Cash413M26.7M1,547%
Total Debt42.5M13M327%
FUNDAMENTALS RATINGS
ALEC vs EYEN: Fundamental Ratings
ALEC
EYEN
OUTLOOK RATING
1..100
711
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9497
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYEN's Valuation (26) in the Pharmaceuticals Major industry is in the same range as ALEC (54) in the Biotechnology industry. This means that EYEN’s stock grew similarly to ALEC’s over the last 12 months.

EYEN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that EYEN’s stock grew similarly to ALEC’s over the last 12 months.

EYEN's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that EYEN’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (94) in the Biotechnology industry is in the same range as EYEN (97) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to EYEN’s over the last 12 months.

ALEC's P/E Growth Rating (93) in the Biotechnology industry is in the same range as EYEN (100) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to EYEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECEYEN
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RVLGF0.25N/A
-1.59%
Revival Gold Inc.
HESAF2570.50-47.90
-1.83%
Hermes International SA
KBCSY44.77-1.14
-2.48%
KBC Group SA
THNPY31.80-1.28
-3.87%
Technip Energies NV
LNVGY25.31-2.07
-7.56%
Lenovo Group Ltd.